FILE PHOTO: A medical staff cleans their hands while caring for a COVID-19 patient in the coronavirus infirmary of the Sheba Medical Center in Ramat Gan, Israel, Oct. 12, 2021. REUTERS / Nir Elias
JERUSALEM – An Israeli hospital confirmed the first known death of a patient with the Omicron variant of COVID-19 in the country on Tuesday, but said he had suffered from a number of serious pre-existing conditions. Soroka Medical Center in Beersheba said the man in his sixties died on Monday, two weeks after he was admitted to the coronavirus ward.
A hospital statement said the patient suffered from a variety of serious illnesses . « His morbidity was mainly due to pre-existing illnesses and not to a respiratory infection from the coronavirus, » it said.
A PCR test led to the suspicion that the Omicron variant was present, so it was used for DNA analysis The statement went on to say.
According to Israeli media reports in the Times of Israel and Ynet, the patient had received two doses of the vaccine.
On Tuesday, the Ministry of Health announced that at least 340 cases of Omicron had occurred in Israel The Israeli government has agreed to reduce the attendance of public sector workers by 50%, Prime Minister Naftali Bennett’s office said in order to encourage more remote working.
The office of Defense Secretary Benny Gantz said he had directed the military’s home front command, charged with anti-pandemic measures, to prepare for the case of 5,000 new cases a day.
You can find more news about the novel coronavirus here.
What you need to know about the coronavirus.
For more information on COVID-19, call the DOH hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our frontliners in the healthcare sector and continues to accept monetary donations that can be paid into the current account of Banco de Oro (BDO) # 007960018860 or donated via PayMaya via this link.
Subscribe to INQUIRER PLUS, to get access to The Philippine Daily Inquirer’s other 70 titles, &, share up to 5 gadgets, listen to the news, download & as early as 4am and share articles on social media. Call 896 6000.
By providing an email address. I agree to the terms of use and
confirm that I have read the privacy policy.
We use cookies to give you the best experience on our website. By continuing, you consent to our use of cookies. To learn more, please click this link.
Keywords:
